Atazanavir sulfate
|
|
|
- CAS-Nr.
- 229975-97-7
- Englisch Name:
- Atazanavir sulfate
- Synonyma:
- Zrivada;Cgp 75355;Aids060276;Aids-060276;BMS-232632-05;BMS232632 sulfate;Atazanavir Sulfate;BMS 232632 sulfate;BMS-232632 sulfate;Atazanavir Sulphate
- CBNumber:
- CB3547456
- Summenformel:
- C38H54N6O11S
- Molgewicht:
- 802.94
- MOL-Datei:
- 229975-97-7.mol
|
Atazanavir sulfate Eigenschaften
- Schmelzpunkt:
- 195.0°, or acetone; mp 198-199° (dec)
- alpha
- D22 -46.1° (c = 1 in 1:1 CH3OH/H2O, pH = 2.6)
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- Löslichkeit
- ≥28.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥4.05 mg/mL in EtOH with gentle warming and ultrasonic
- Aggregatzustand
- Powder
Atazanavir sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Atazanavir (BMS-232632, III), an azapeptide HIV
protease inhibitor, has been developed and launched by
Bristol-Myers Squibb (BMS), under worldwide license from
Novartis, for the treatment of HIV infection. Atazanavir
was launched in the US as Reyataz™ in July 2003.
Chemische Eigenschaften
Off-White Solid
Verwenden
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM
Atazanavir sulfate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Atazanavir sulfate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 289)Lieferanten
229975-97-7()Verwandte Suche:
- 1-(4-Biphenylyl)-4(S)-hydroxy-5(S)-2,5-bis{[N-(methoxycarbonyl-)-L-tert-leucinyl]amino}-6-phenyl-2-azahexane
- Aids060276
- Aids-060276
- Cgp 75355
- Methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(Methoxycarbonyl)aMino]-3,3-diMethyl-N'-{[4-(pyridin-2-yl)phenyl]Methyl}butanehydrazido]-1-phenylbutan-2-yl]carbaMoyl}-2,2-diMethylpropyl]carbaMate
- Atazanavir sulfate (BMS-232632-05)
- BMS-232632-05
- Zrivada
- (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid 1,14-dimethyl ester, sulfate (1:1)
- methyl((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamatesulfate
- Atazanavir Sulfate
- Atazanavir Sulphate
- Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate
- N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-1-oxobutyl]amino]-4-phenylbutyl]-2-[(4-phenylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamic acid methyl
- BMS 232632 sulfate
- BMS 232632 SULFATE;BMS-232632 SULFATE;BMS232632 SULFATE
- BMS232632 sulfate
- BMS-232632 sulfate
- Atazanavir sulfate, 99%, HIV protease inhibitors
- Atazanavir (BMS-232632) sulfate
- Methyl {(5S,10S,11S,14S)-11-benzyl-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-8-[4-(2-pyridinyl)benzyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl}carbamate
- ATAZANAVIR SULFATE (BMS-232632 SULFATE)
- Atazanavir sulfate CRS
- ((5S,6S)-5-hydroxy-1,8-dioxo-6-(phenyl methyl)-3-[[4-(2-
pyridinyl)phenyl]methyl] -2,3,7 triaza octane dioic acid
tertiary butyl ester)
- Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate
- Atazanavir sulfate USP/EP/BP
- Atazanavir Sulfate (Latazanavir, Zrivada, Reyataz, BMS232632)
- Atazanavir sulfateQ: What is
Atazanavir sulfate Q: What is the CAS Number of
Atazanavir sulfate Q: What is the storage condition of
Atazanavir sulfate Q: What are the applications of
Atazanavir sulfate
- Atazanavir Sulfate (1044334)
- 229975-97-7
- C38H52N6O7H2SO4
- Inhibitor
- Atazanavir
- Antiviral Agents
- Inhibitors
- peptides
- BMS-232632-05, Reyataz
- 229975-97-7
